1[1]Brundin P, Duan WM, Sauer H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum, In Dunnett SB, Bjorklund A, eds. Functional Neural Transplantation. New York: Raven Press, 1994. 46.
2[2]Annett LE. Functional studies of neural grafts in parkinsonian primates, In Dunnett SB, Bjorklund A, eds. Functional Neural Transplantation. New York: Raven Press, 1994. 102.
3[3]Brundin P, Pogarell O, Hagell P, et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain, 2000, 123:1380-1390.
4[4]Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol, 1995, 38:379-388.
5[5]Hagell P, Schrag A, Piccini P, et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain, 1999,122:1121-1132.
6[6]Hauser RA, Freeman TB, Snow B J, et al. Long term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol,1999, 56:179-187.
7[7]Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.Science, 1990, 247:574-577.
8[8]Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol, 1994, 35:172-180.
9[9]Mendez I, Dagher A, Hong M, et al. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line derived neurotrophic factor in patients with Parkinson's disease: report of two cases and technical considerations. J Neurosurg, 2000, 92:863-869.
10[10]Peschanski M, Defer G, N Guyen JP, et al: Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain, 1994, 117:487-499.
